Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs include ONC201 a program for treating tumors which harbor the H3 K27M mutation in recurrent diffuse midline glioma patients; ONC206, an imipridone, Dopamine Receptor D2 (DRD2) antagonist, and caseinolytic protease P (ClpP) agonist that demonstrated enhanced non-competitive DRD2 antagonism relative to ONC201, which is in Phase I clinical trials to treat solid tumors; ONC212, an imipridone agonist of the orphan G protein-coupled receptors (GPCR) tumor suppressor GPR132, as well as ClpP for solid tumors and hematological malignancies, including pancreatic cancer and leukemias; and dociparstat sodium (DSTAT), which inhibits the activities of key proteins implicated in the resistance of acute myeloid leukemia blasts and leukemic stem cells to chemotherapy. The company has license agreements with Biomedical Advanced Research and Development Authority for the development of brincidofovir for use in the treatment of smallpox; Cantex Pharmaceuticals, Inc. to develop and commercialize a glycosaminoglycan compound; and SymBio Pharmaceuticals to develop, manufacture, and commercialize BCV for various human indications. Chimerix, Inc. was incorporated in 2000 and is headquartered in Durham, North Carolina. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Chimerix Inc..
Chimerix Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Chimerix Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Chimerix Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Chimerix Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Chimerix Inc. and all latest updates of the company are provided.
The 2025 version of Chimerix Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Chimerix Inc.- Key Facts
2.2 Chimerix Inc.- Geographic Locations
2.3 Chimerix Inc.- Subsidiaries and Affiliates
2.4 Chimerix Inc.- Business Divisions
2.5 Chimerix Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Chimerix Inc. Strategic Analysis Review
3.1 Chimerix Inc.- Key Strategies
3.2 Chimerix Inc.- Company Outlook Statement
3.3 Chimerix Inc.- SWOT Analysis
3.3.1 Chimerix Inc.- Key Strengths
3.3.2 Chimerix Inc.- Key Weaknesses
3.3.3 Chimerix Inc.- Potential Opportunities
3.3.4 Chimerix Inc.- Potential Threats
3.4 Chimerix Inc.- Key Competitors
4. Business Description of the Company
4.1 Chimerix Inc.- Business Overview
4.2 Chimerix Inc.- Operations by Segment
5 Products and Services Details
5.1 Chimerix Inc.- Key Products
5.2 Chimerix Inc.- Key Service Areas
5.3 Chimerix Inc.- Key Brands
6 Company Developments
6.1 Chimerix Inc.- Company History
6.2 Chimerix Inc.- Latest Developments
7 Financial Analysis
7.1 Chimerix Inc.- Income Statements
7.2 Chimerix Inc.- Balance Sheet
7.3 Chimerix Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Chimerix Inc.- Direct Competitors
8.2 Chimerix Inc.- Competitor Financial Ratios comparison
8.3 Chimerix Inc.- Competitor Stock Charts Comparison
8.4 Chimerix Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!